NK cells possess inhibitory receptors that are responsible for self-MHC class I recognition; beyond their inhibitory function, accumulating evidence indicates that such receptors confer NK cell functional competence through an unclear process termed "licensing." Ly49C is the main self-specific inhibitory Ly49 receptor in H-2 b C57BL/6 (B6) mice. We used B6 Ly49C-transgenic and B6 b2 microglobulin (b2m)-knockout Ly49C-transgenic mice to investigate the impact of licensing through this inhibitory receptor in precursor and mature NK cells. We found that self-specific inhibitory receptors affected NK cell precursor survival and proliferation at particular developmental stages in an MHC class I-dependent manner. The presence of Ly49C impacted the NK cell repertoire in a b2m-dependent manner, with reduced Ly49A + , Ly49G2 + , and Ly49D + subsets, an increased DNAM-1 + subset, and higher NKG2D expression. Licensed NK cells displayed a skewed distribution of the maturation stages, which was characterized by differential CD27 and CD11b expression, toward the mature phenotypes. We found that Ly49C-mediated licensing induced a split effect on NK cell functions, with increased cytokine-production capabilities following engagement of various activating receptors while cytotoxicity remained unchanged. Analysis of licensed NK cell functions in vivo, in a system of mouse CMV infection, indicated that licensing did not play a major role in the NK cell antiviral response during acute infection, but it strongly impaired the generation and/or persistence of memory NK cells. This study unravels multifaceted effects of licensing on NK cell populations and their functions.
N atural killer cells constitute a population of lymphocytes that plays an important role in immune protection against pathogens and cancer cells. Unlike T and B lymphocytes, NK cells do not express receptors generated through gene recombination; rather, they possess an array of germline-encoded activating and inhibitory receptors. Selective or stochastic expression of these receptors creates the repertoire diversity (1) . Integration of intracellular signals mediated through these receptors finely controls the functions of mature NK cells. The functional capacity and maturation of peripheral NK cells are affected by environmental factors, such as the presence of inflammatory cytokines and accessory cells (2) (3) (4) . NK cells are part of the innate arm of the innate immune system; as a result of the nature of their repertoire, they respond promptly without requiring a preliminary phase of selection and expansion. In addition, NK cells possess the ability to differentiate into memory cells, a feature that, until recently, was considered an attribute of adaptive lymphocytes; memory NK cells are long-lived and specifically exhibit increased cytotoxic and inflammatory cytokine-production capabilities, thereby providing better antiviral protection (5) (6) (7) (8) .
NK cell development occurs in the bone marrow after birth. During this process, NK cell precursors acquire a finite set of receptors and undergo education that is regulated through molecular mechanisms that are not fully understood. Discrimination of self by NK cells is primarily supported by MHC class I (MHC I)specific inhibitory receptors; in the mouse, classical MHC I molecules are recognized by members of the C-type lectin Ly49 receptor family, whereas nonclassical MHC I Qa-1 molecules are recognized by the CD94-NKG2A/C/or E heterodimeric receptors. In H-2 b C57BL/6 (B6) mice, Ly49C is the main inhibitory Ly49 receptor responsible for self-MHC I recognition; it was documented that this receptor confers NK cell functional competence through "licensing" (9) . Licensing may be a positive process (arming) that provides constitutively inactive NK cell precursors with function; alternatively, NK cells may be active by default and become hyporesponsive as a result of uncontrolled and sustained activation signals during development in the absence of self-specific inhibitory receptors (disarming) (1) . We use the term "licensing" to describe the education process that generates functional NK cells and relies on the expression of self-specific inhibitory receptors, regardless of the underlying mechanisms. Similarly, mature NK cells become hyporesponsive (exhaustion) as a result of unregulated chronic stimulation (10) (11) (12) ; whether the mechanisms involved in this process of peripheral tolerance are similar or differ from those occurring during education (central tolerance) remains to be defined. Knockout (ko) mice lacking Ly49 receptors exhibited defective missing self recognition, which resulted in impaired elimination of MHC I-deficient tumor cells in vivo, whereas activation pathways, such as NKG2D and Ab-mediated target cell recognition, were preserved (13) . This regulation pattern of NK cell function is not unique to mice. In humans, NK cell subsets lack self-specific KIRs.
The absence of inhibition does not result in autoimmunity; instead, such NK cells are hyporeactive. In contrast, NK cell subsets that express self-specific KIRs respond strongly to stimulation (14) (15) (16) . In mice and humans, individuals with deficient MHC I expression possess a poorly functional NK cell population (17) (18) (19) (20) . Although accumulating evidence indicates that self-specific inhibitory receptors play a critical role in NK cell education, it remains unclear whether licensing positively impacts all aspects of NK cell fitness or whether this regulation is restricted to particular aspects of NK cell biology. Also, improvement in NK cell function by licensing was questioned in the context of antiviral (mouse CMV [MCMV]) (21) and antitumoral protection (22) , where unlicensed NK cells were found to dominate the response.
In this study, we sought a better understanding of the impact of licensing exerted by a self-specific inhibitory receptor, Ly49C, on NK cell development, repertoire acquisition, maturation and memory differentiation of peripheral NK cells, and NK cell functions in well-controlled in vitro systems and in integrated in vivo conditions following infection by MCMV. We conducted this study in B6 wild-type (WT) mice in which we compared the unlicensed Ly49C 2 and licensed Ly49C + subsets. Also, we generated novel B6 Ly49C-transgenic (Tg) and B6 b2 microglobulin (b2m) 3 Ly49C-Tg (B6 b2m ko Ly49C-Tg) mouse strains; Ly49C-Tg mice were used to examine the role of Ly49C when the entire NK cell population expresses this receptor and, therefore, is supposedly licensed. In parallel, we analyzed the effect in a b2mdeficient environment, where the severely reduced expression of ligands (MHC I) for Ly49C allowed us to examine the importance of Ly49C engagement by MHC I molecules in NK cell education.
Materials and Methods

Ethics statement
All animal experiments were performed after approval by the Animal Ethics and Experimentation Committee of the University of Western Australia (approval #RA/3/300/76, #RA/3/300/99, #RA/3/100/1079, and #RA/3/ 100/1094) and in accordance with the guidelines of the National Health and Medical Research Council of Australia.
Animals
Inbred B6 WT mice were obtained from the Animal Resources Centre (Perth, WA, Australia). B6 Ly49C-Tg, B6 b2m-ko, B6 b2m-ko Ly49C-Tg, and B6.BALB-TC1 (H-2 b , Ly49H 2 ) congenic mice were bred at the University of Western Australia Animal Care Services (Perth, WA, Australia). Female mice aged 7-15 wk were used for experiments performed in specific pathogenfree conditions.
Ly49C-Tg mouse strains
Splenic NK cells isolated from a B6 mouse were expanded in recombinant human IL-2 (Cell Sciences, Canton, MA). mRNA was isolated using a PureLink RNA Mini Kit (Thermo Fisher Scientific, Waltham, MA), and a 907bp-long ly49cb6 cDNA was amplified by PCR using the following primers: forward, 59-CTC CAC CAG CAT CAC TCC G-39 and reverse, 59-CAA GAA ACG AAT AAG GAT CAA CTC-39. A 850-bp product harboring Sal1 and BamH1 ends was generated by amplifying the ly49cb6 cDNA using the following primers: forward, 59-TAT ATG TCG ACC TCC ACC AGC ATC ACT CCG-39 and reverse, 59-TAT ATG GAT CCT TAA TCA GGG AAT TTA TCC-39. The ly49cb6 insert was inserted into the modified transgene cassette described previously (23) and microinjected into fertilized B6 eggs; five founders were obtained and mated to B6 WT mice. Appropriate offspring were identified by FACS analysis for Ly49C expression and checked by PCR; selected mice from the same dam were intercrossed, and four Tg lines were generated. B6 Ly49C-Tg mice were mated with B6 b2m-ko mice, and the b2m heterozygous 3 Ly49C-Tg F1 progeny were intercrossed. Offspring were tested for b2m by PCR and by flow cytometry, and b2m-ko mice were used as founders for the homozygous B6 b2m-ko Ly49C-Tg colony.
Cell lines
RMA, RMAS, YAC-1, and CHO cells were grown in RPMI 1640 containing 5% FCS (Invitrogen), glutamine, sodium pyruvate, penicillin, gentamicin, and 2-ME. Preparation of RMA H60 was described (10) . M210B4 cells were maintained in MEM 10% neonatal calf serum (Invitrogen). CD155expressing RMA and RMAS cells were prepared as follows: DNA was extracted from B6 mouse thymocytes using a QIAquick PCR purification kit (QIAGEN), and CD155 was amplified using the following primers: forward, 59-TAT ATC TCG AGC CAC ATG GCT CAA CTC GCC-39 and  reverse 59-TAT ATG CGG CCG CTC ACC TTG TGC TGT TTG G-39. The PCR product was ligated within a pEF-IRES-Puro expression vector between the XhoI and NotI restriction sites and used to transform DH5acompetent cells. Positive colonies were identified by PCR, and 10 mg DNA from Midiprep products was inserted by electroporation into RMA and RMAS cells. Cells were grown in selective medium containing puromycin for 1 wk until analysis for CD155 expression by flow cytometry. Clonal populations were selected after limit-dilution culture.
Abs
Abs directed against b2m (S19.8), CD3ε (145.2C.11), CD11b (M1/70), CD16 (2.4G2), CD19 (1D3), CD45.1 (A20), CD45.2 (104), CD49b (DX5), CD69 (H1-2F3), CD107a (1D4B), CD161/NK1.1 (PK136), CD244.2 (2B4), IFN-g (XMG1.2), mouse IgG1 (A851), KLRG1 (2F1), Ly6C (AL21), Ly6C and G/Gr1 (RB6-8C5), Ly49D (4E5), Ly49G2 (4D11), NKG2A/C/E (20D5), and TER-119 (TER-119) were obtained from BD Biosciences (San Diego, CA). Anti-CD27 (LG7F9) and anti-CD155 (TX56) were obtained from eBioscience (San Diego, CA). Anti-CD90.2/Thy1.2 (30H12), anti-CD122 (TM-b1), anti-CD226/DNAM-1 (480.1), anti-CD335/ NKp46 (29A1.4), and anti-Ly49A (YE1/48) were obtained from BioLegend (San Diego, CA). Anti-NKG2D (FAB1547) was obtained from R&D Systems (Minneapolis, MN). Abs specific for Ly49H (3D10) and Ly49C (4LO3311) were produced in-house following hybridoma culture Ab purification and conjugation to Alexa Fluor 488 and Alexa Fluor 647 fluorochromes using a labeling kit (Invitrogen Molecular Probes).
Staining for flow cytometry analysis
Cells were incubated for 30 min at 4˚C with PBS 10% goat serum for blocking of nonspecific binding. Cells were incubated with specific Abs for 30 min at 4˚C, followed by a 5-min incubation with propidium iodide for dead cell exclusion. For detection of Ly49C, cis interactions with H-2 K b were released by mild acid treatment in citrate buffer (0.133 M citric acid, 0.066 M Na 2 HPO 4 [pH 3.3]) prior to staining, as described (24) . BrdU incorporation was measured after cell surface staining and fixation using Cytofix/Cytoperm buffer (BD Biosciences), followed by Cytoperm Plus and 1 h of DNase treatment at 37˚C, according to the manufacturer's recommendations. The cells were stained with anti-BrdU for 20 min at ambient temperature. Detection of extracellular phosphatidylserine on apoptotic cells was performed using Annexin V (BD Biosciences), according to the manufacturer's recommendations. For the detection of intracellular IFN-g and degranulation (CD107a), NK cells were cultured at 37˚C in the presence of 2 mg/ml monensin (Sigma-Aldrich, St. Louis, MO). For CD107a analysis, anti-CD107a Ab was added to the culture medium, as described (25) . After crosslinking stimulation or culture with target cells, NK cells were stained with fluorochrome-conjugated Abs, fixed with Cytofix/Cytoperm, permeabilized with Perm/Wash according to the manufacturer's recommendations (BD Bioscience), and stained intracellularly for anti-IFN-g. Cells were analyzed using a BD FACSCanto or FORTESSA X-20 (BD Biosciences). Analysis of flow cytometry data was performed using FlowJo software. and rinsed once with PBS. A total of 3 3 10 5 splenic NK cells was seeded in 200 ml primary cell culture medium (DMEM 10% FCS, L-glutamine, sodium pyruvate, nonessential amino acids, 2-ME, gentamicin) containing 250 ng/ml recombinant human IL-2 and 2 mg/ml monensin (Sigma-Aldrich) and incubated for 15 h at 37˚C in 5% CO 2 atmosphere. Uncoated wells were used as negative control (background response), whereas addition of 50 ng/ml PMA and 500 ng/ml ionomycin (both from Sigma-Aldrich) provided maximal response. NK cells were stained for CD3ε and NK1.1 for NK cell gating, fixed, and stained for intracellular IFN-g, as noted above.
In vitro NK cell stimulation with target cells B6 WT, B6 Ly49C-Tg, B6 b2m-ko, and B6 b2m-ko Ly49C-Tg mice were injected i.p. with 50 mg polyinosinic-polycytidylic acid [poly(I:C); Sigma-Aldrich]; the spleens were collected 16 h later. A total of 1 3 10 5 enriched NK cells and 2 3 10 5 target cells were mixed in 96-well plates (Falcon; Corning, Clayton, VIC, Australia) in 200 ml primary cell culture medium containing 250 ng/ml recombinant human IL-2, 2 mg/ml monensin, and anti-CD107a Ab, incubated for 5 h at 37˚C in 5% CO 2 atmosphere, and tested for intracellular IFN-g and degranulation (CD107a).
Determination of virus growth in vivo
Mice were injected i.p. with the indicated dose of K181 strain MCMV. Mice were sacrificed 4 d postinfection; spleen and liver were collected, homogenized in cold MEM 2% neonatal calf serum (Life Technologies), and centrifuged at 3000 rpm for 15 min at 4˚C. The supernatants were stored at 280˚C, and viral titers were quantified by standard plaque assay on M210B4 cells, as described (26) .
In vivo memory NK cell assay
Spleens were harvested from congenic CD45.1 B6 and CD45.2 B6 Ly49C-Tg mice. Splenic NK cells were enriched using an EasySep NK Cell Negative Selection Kit (STEMCELL Technologies) and stained with anti-NK1.1 (PK136), CD3ε (145.2C.11), Ly49H (3D10), and Ly49C (4LO3311) fluorochrome-conjugated Abs for cell sorting using a BD Influx cell sorter (BD Biosciences). NK cells from congenic CD45.1 B6 mice were sorted into Ly49H + C 2 and Ly49H + C + subsets, whereas Ly49H + C + NK cells were purified from B6 Ly49C-Tg mice. A 1:1:1 NK cell mix (50 3 10 3 NK cells from each sorted group) was injected i.v. into B6.BALB TC1 (CD45.2, Ly49H 2 ) mice, and the mice were infected with 5 3 10 3 PFU MCMV on the following day. Two weeks postinfection, blood samples were collected, and the frequency of Ly49H + NK cells from each of the transferred groups was determined by flow cytometry. Four weeks postinfection, mice were sacrificed, blood and spleens were collected, and the persistence of long-lived memory Ly49H + NK cells was measured by flow cytometry.
Statistical analysis
For statistical analysis, groups were compared with the nonparametric Student t test (two-tailed) using the statistical software package GraphPad Prism (GraphPad, La Jolla, CA); the paired student t test (two-tailed) was used for paired analyses. Groups were considered significantly different at p , 0.05.
Results
Generation of Ly49C-Tg mice
We created a Ly49C-Tg mouse strain by integrating a vector encoding a Ly49C transgene in the B6 mouse background. We used a modified transgene cassette (23) to drive Ly49C expression. The ly49cb6 gene is controlled by an H-2K b promoter and an IgH enhancer ( Fig. 1A ). This vector was used by other investigators to express Ly49 receptors (27, 28) . Ly49C-Tg mice were designed so that Ly49C would be expressed on the entire NK cell population ( Fig. 1B) . B6 Ly49C-Tg mice were further bred with b2mdeficient B6 mice (B6 b2m ko) to create a double-mutant B6 b2m-ko Ly49C-Tg mouse. The endogenous ligand for Ly49C in B6 mice is the H-2 K b MHC I molecule; the absence of b2m results in severely reduced MHC I expression. The double-mutant b2m ko Ly49C-Tg model was generated to discriminate the effects due to expression of Ly49C from those due to engagement by its ligand. We analyzed peripheral NK cells for Ly49C expression in the blood (Fig. 1B ) and the spleen (Fig. 1C ) in the B6 WT, B6
Ly49C-Tg, B6 b2m-ko, and B6 b2m-ko Ly49C-Tg mouse strains. Ly49C is able to also bind H-2 K b expressed on the same cellular membrane vicinity through cis interaction; the epitope recognized by the anti-Ly49C Ab (4LO3311) is masked when Ly49C is engaged in cis. Thus, in MHC I (H-2 b )-expressing mice, optimal detection of Ly49C (both cis-engaged and free receptors) by flow cytometry requires a preliminary acidic treatment that releases interactions in cis (24) . We found that .95% of NK cells expressed Ly49C in Tg mice, both in the b2m-sufficient and -deficient backgrounds, whereas Ly49C expression is limited to 20-30% of NK cells in B6 WT and B6 b2m-ko mice (Fig. 1B, 1C ).
Impact of Ly49C expression during NK cell development
NK cells develop from common lymphoid progenitors within the bone marrow. NK cell precursors evolve through subsequent developmental stages that can be discriminated by flow cytometry based on the sequential acquisition of surface molecules. A study from Yokoyama's group (29) cells but are negative for lineage markers of other immune cell types (T and B lymphocytes, dendritic cells, macrophages, erythroid cells, polynuclear cells), acquisition of NK1.1 and then of c-kit defines stages II/III, DX5 expression characterizes stage IV precursors, and increased expression of CD11b marks the final stage (V) where NK cells are fully developed (29, 30) . We studied the impact of Ly49C expression on NK cell development in b2msufficient and -deficient mice. Similar total numbers of bone marrow cells were found in WT, Ly49C-Tg, b2m-ko, and b2m-ko Ly49C-Tg mouse strains ( Fig. 2A ), but decreased numbers of NK1.1 + cells (stage II onward) were measured in Ly49C-Tg mice with b2m-sufficient and -deficient backgrounds (Fig. 2B ). We next analyzed at which stage of development Ly49C expression started. We detected Ly49C from stage I in small populations at low expression density in non-Tg mice (data not shown); gradually, Ly49C was observed in larger proportions of cells, with simultaneously increased expression levels, until the terminal expression pattern was achieved at stages IV/V (Fig. 2C ). In Tg mice, Ly49C was detected on 80% of the stage I precursors, and maximal expression was observed from stage II/III, regardless of the presence of b2m ( Fig. 2C ). Next, we addressed whether early expression of Ly49C in Tg mice affected the kinetics of NK cell development. The early and broad expression of Ly49C did not significantly alter the distribution of precursors at the successive developmental stages ( Fig. 2D ). Then, we analyzed developing NK cell proliferation using BrdU incorporation in vivo. Rare BrdU + cells were observed at early stages of development (stage II/III); however, at later stages, Ly49C expression resulted in higher frequencies of replicating cells in a b2m-restricted manner ( Fig. 2E ). We also studied apoptosis in developing NK cells based on annexin V staining, which identifies the phosphatidylserine flip from the inner to the outer side of the cellular membrane that occurs in apoptotic cells. Apoptotic cells were more frequent at early developmental stages (II/III) than at late stages in all of the mouse strains, indicating that most precursor deletion occurred early during development. Ly49C-Tg mice displayed higher apoptosis rates at late stages, which was worse in the presence of b2m ( Fig. 2F ). However, in non-Tg mice, the occurrence of apoptosis was not different in the Ly49C 2 and Ly49C + subsets ( Fig. 2F ). Therefore, expression of the self-specific inhibitory receptor results in increased proliferation and apoptosis of NK cell precursors but does not affect kinetics of NK cell development.
Impact of Ly49C expression on the NK cell repertoire
The ability of NK cells to recognize multiple types of ligands relies on a panel of germline-encoded activating and inhibitory receptors; expression of some receptors is induced during development, whereas others remain silent through regulatory mechanisms that are mostly unknown. We studied the effect of Ly49C expression on the NK cell repertoire in splenic mature NK cells. Ly49C expression resulted in decreased frequencies of NK cells expressing Ly49A, Ly49G2, and Ly49D ( Fig. 3 ). These regulatory effects of Ly49C over the Ly49 repertoire distribution confirmed the findings from a previous study (31) . We observed a larger fraction of NK cells expressing DNAM-1 in Ly49C-Tg mice than in WT mice ( Fig. 3 ). NKG2D is an activating receptor that is ubiquitously present on NK cells. Broad expression of Ly49C in the Tg mice did not alter the ubiquitous distribution of NKG2D (data not shown); however, its expression levels were increased by 35%, on average, compared with WT NK cells ( Fig. 3) . No changes were observed in 2B4 expression. Changes in Ly49A, Ly49G2, and NKG2D expression were observed only in the presence of b2m, whereas changes in Ly49D and DNAM-1 were observed even in the absence of b2m ( Fig. 3 ), suggesting that expression of these receptors is regulated through different mechanisms.
Impact of Ly49C expression on peripheral NK cells
We evaluated whether Ly49C expression affected peripheral NK cells. Similar total numbers of splenocytes were observed in B6 WT and B6 Ly49C-Tg mice, whereas in the absence of b2m, presence of the Ly49C transgene resulted in decreased cellularity ( Fig. 4A ). A larger splenic NK cell population was present in B6 Ly49C-Tg mice than in B6 WT mice, and change was dependent on the presence of b2m (Fig. 4B ). In the periphery, the functional capabilities of NK cells evolve as they differentiate from less mature to more mature subsets. NK cell maturation stages can be discriminated based on CD27 and CD11b expression. As NK cells mature CD27 is downregulated; conversely, CD11b is expressed at higher density (32) . In WT and b2m-ko backgrounds, the most mature CD27 lo CD11b hi subset was the most abundant, whereas the less mature CD27 hi CD11b lo subset and the intermediate CD27 hi CD11b hi subset together represented no more than half of the total population. Expression of Ly49C in B6 WT and B6 Ly49C-Tg mice was associated with further prevalence of the most mature CD27 lo subset. This subset was the most abundant in b2m-deficient mice, but it was not increased further in b2m-ko Ly49C-Tg mice (Fig. 4C ). Next, we analyzed peripheral NK cell proliferation based on BrdU incorporation. In all mouse strains we measured higher frequencies of BrdU + cells within the CD27 hi maturation stage compared with the late CD27 lo maturation stage ( Fig. 4D ). Ly49C was associated with increased proliferation within the early CD27 hi CD11b lo subset in B6 WT mice (Fig. 4D ). In addition, BrdU + cells were more frequent in B6 Ly49C-Tg mice than in B6 WT mice at the intermediate CD27 hi CD11b hi stage; a trend for increased proliferation in Ly49C-Tg mice compared with WT mice was also seen at the early CD27 hi CD11b lo stage. However, in the absence of b2m, Ly49C was not associated with increased proliferation of CD27 hi NK cells (Fig. 4D) . These results indicate that Ly49C expression in the presence of ligands promotes proliferation of CD27 hi NK cells in the periphery. The size of the peripheral NK cell population results from the combined effect of cell proliferation and death. We analyzed apoptosis using annexin V staining, as indicated above. Labeling with annexin V was detected on a higher frequency of cells in the early CD27 hi CD11b lo subset compared with more mature cells, but apoptosis was not affected by Ly49C in B6 WT mice; however, increased apoptotic rates were detected in B6 Ly49C-Tg cells compared with B6 WT NK cells in a b2m-dependent manner ( Fig. 4E ). Thus, expression of self-specific Ly49C in the presence of H-2 ligands alters the size and maturation of the peripheral NK cell population through mechanisms associated with altered proliferation and apoptosis.
Impact of Ly49C on NK cell responses upon receptor cross-linking stimulation
We addressed whether Ly49C-mediated licensing improves the efficacy of activating receptors. Splenic NK cells were isolated from naive mice, purified, and stimulated by cross-linking activating receptors on Ab-coated plates ex vivo. Presence of intracellular IFN-g was used as read-out for NK cell responsiveness. As negative controls, NK cells were plated on uncoated wells, and the background IFN-g production was subtracted from the values FIGURE 3 . Impact of Ly49C expression on NK cell repertoire. Frequency of splenic NK cells expressing Ly49A, Ly49G2, NKG2A/C/E, Ly49H, Ly49D, and DNAM-1 was analyzed in B6 WT, B6 Ly49C-Tg, B6 b2m-ko, and B6 b2m-ko Ly49C-Tg mice. Level of expression (MFI values) of NKG2D and 2B4 in B6 Ly49C-Tg and B6 b2m-ko Ly49C-Tg mice was normalized based on the values obtained from non-Tg B6 WT and B6 b2m-ko mice, respectively, used as reference (100%). Data are mean 6 SEM of 7-12 individual mice/strain. *p , 0.05, Student t test. obtained following receptor cross-linking to provide values corresponding to specifically induced responses. NK cells were also stimulated with PMA and ionomycin to bypass the receptors and directly address their intrinsic IFN-g-production capability. We found that PMA + ionomycin triggered a strong IFN-g response in the entire NK cell population in all of the mouse strains ( Fig. 5A ). NK cells were much more responsive to NK1.1, NKp46, NKG2D, and Ly49H stimulation in B6 Ly49C-Tg mice than in B6 WT mice ( Fig. 5A ). More responding NK cells were also observed in response to DNAM-1 and CD16 stimulation, although cross-linking of these receptors resulted in very small populations of responding cells. Weak IFN-g responses were detected in NK cells isolated from b2m-deficient mice, which correlates with previous findings indicating that NK cell functions are impaired, in part, in an environment devoid of MHC I molecules (18) . No gain of IFN-g function associated with the Ly49C transgene was observed in the b2m-deficient background (Fig. 5A ). In addition to the frequency of IFN-g + NK cells, we analyzed the extent of IFN-g accumulation within responding cells (Fig. 5B ). Because the mean fluorescence intensity (MFI) fluctuates from one experiment to another as a result of the variability inherent to the assay, we conducted a paired analysis and independently compared the samples obtained from the same experiment instead of combining the data from multiple experiments. Greater IFN-g accumulation was obtained in response to NK1.1, NKp46, NKG2D, Ly49H, and Ly49D stimulation in B6 Ly49C-Tg NK cells than in B6 WT NK cells.
No significant differences were detected in NK cells isolated from mice deficient for b2m ( Fig. 5B) . These results indicate that Ly49C expression is associated with an improved IFN-g response, both at the level of the frequency of producing cells and at the level of production intensity, following direct stimulation of multiple activating receptors. This improved capability requires the presence of the MHC I ligand for Ly49C.
Impact of Ly49C on NK cell responses upon exposure to target cells
Cross-linking activating receptors with Abs is a well-recognized and widely used method to address the functionality of independent receptors, but these experimental conditions do not reflect the complexity of the intercellular interactions between NK cells and their targets during which signals generated through a variety of receptors and adhesion molecules are integrated. In this study, we tested how Ly49C-mediated licensing affects NK cell responses against target cells expressing ligands for various activating receptors. Mice received poly(I:C) to reproduce inflammatory conditions induced by exposure to pathogens, such as a viral infection, to presensitize NK cells before testing their functions immediately after collection. Two major NK cell functions, IFN-g production and cytotoxicity quantified by CD107a surface expression, were measured. We tested multiple activation pathways using a panel of target cells. RMAS cells (MHC I lo ) were used to test missing selfrecognition, the NKG2D-dependent activation pathway was tested against YAC-1 cells, Ly49D function was tested against CHO cells, the DNAM-1-dependent pathway was tested against CD155-expressing RMAS cells, and Ab-dependent cell cytotoxicity through CD16 was tested against RMAS cells prelabeled with anti-Thy1.2 Abs. We used the RMAS rather than the RMA cell line as targets because expression of H-2 K b on the latter induced a dominant Ly49C-mediated inhibition in Ly49C-Tg NK cells that impaired the activating receptor response (Supplemental Fig. 1 ); this result indicated that strong inhibitory signals offset the functional benefit provided by licensing. It is important to note that poly(I:C) does not alter the specificity of the NK cell response; nevertheless, to ensure that this treatment did not bias the response pattern, we also tested NK cells from untreated mice. As expected, they displayed qualitatively similar responses but of lower intensity (data not shown). Higher frequencies of NK cells producing IFN-g were observed in Ly49C-Tg than in B6 WT following exposure to YAC-1-, CHO-, and Thy1.2-opsonized cells (Fig. 6A) , which confirmed the results obtained by crosslinking NKG2D, Ly49D, and CD16, respectively. We also investigated whether more IFN-g was produced in the responding cells in a paired analysis, as described above. We found that IFN-g was produced in increased quantities in NK cells from Ly49C-Tg mice compared with in WT mice with all of the target cell types tested (Fig. 6B) . However, NK cell cytotoxic activity was not increased in Ly49C-Tg NK cells (Fig. 6C) , indicating that licensing differentially affects NK cell functions. Our results also showed that licensing was not associated with a generalized improved responsiveness; instead, improved responses were restricted to some activation pathways. NK cells isolated from b2m-deficient mice responded weakly following exposure to YAC-1 and CHO cells and failed to respond to the other cells, which correlates with the recognized hyporeactivity of NK cells in an MHC I-devoid environment. The extent of hyporeactivity that we observed in b2mko Ly49C-Tg mice was even more severe ( Fig. 6 ) and correlated with high expression of Ly49C (Fig. 1C ).
Impact of Ly49C on NK cell responses to MCMV infection in vivo
A previous study reported that unlicensed NK cells dominate the response to MCMV infection (21) . We further addressed, in vivo, how licensing through Ly49C affects the antiviral NK cell response. B6 WT and B6 Ly49C-Tg mice were infected with 1 3 10 4 PFU of MCMV; spleens were collected and NK cells were analyzed 4 d later (Fig. 7A ). Similar percentages of NK cells were found in the spleen in both mouse strains; the proportions of MCMV-specific Ly49H + NK cells also were not significantly different. However, more NK cells displayed activation markers, such as CD69 and KLRG1, in Ly49C-Tg mice than in B6 WT mice (Fig. 7A ). In both mouse strains, no replicating virus was detectable in the spleen, indicating that NK cells had completely controlled the virus in this tissue (data not shown). To further compare NK cell efficacy at controlling viral infections in B6 WT and Ly49C-Tg mice, we analyzed the viral infection resulting from a higher infection dose (5 3 10 4 PFU). We quantified the amounts of virus present in the spleen and liver at 4 d postinfection, a time when NK cells play a major role in antiviral protection and the contribution of virus-specific T cells is negligible (33) . At this higher dose, replicating virus could be detected in these organs, but viral titers were not significantly different in B6 WT and B6 Ly49C-Tg mice. These results indicated that NK cells elicited similar protection in both mouse strains and that generalized Ly49C licensing did not improve NK cell-mediated antiviral immunity against MCMV (Fig. 7B) . It is documented that long-lived Ly49H + NK cells with memory-like features differentiate in B6 mice infected by MCMV (5) . We investigated whether Ly49C affected the ability of NK cells to differentiate into memory cells during the course of MCMV infection. We set up an in vivo experimental approach based on the transfer of sorted NK cell subsets into recipient mice devoid of MCMV-specific NK cells (Ly49H), similar to the system described previously (5) . Unlicensed Ly49H + /Ly49C 2 (Ly49H + C 2 ) and licensed Ly49H + C + cells were isolated from CD45.1 + congenic B6 mice, whereas Ly49H + C + cells were isolated from CD45.2 + B6 Ly49C-Tg mice. A 1:1:1 mix (50 3 10 3 of each of the three cell subsets) was transferred i.v. into TC1 mice (congenic B6 Ly49H 2 , CD45.2 + ) 1 d prior to infection with 5 3 10 3 PFU of MCMV. Two weeks later, circulating NK cells were analyzed in blood samples; at 4 wk postinfection, the mice were sacrificed, and generation/persistence of memory cells in blood and splenic NK cells were analyzed. Donor-derived NK cells were identified based on Ly49H + expression, and the three transferred subsets were further discriminated according to CD45.1/2 and Ly49C expression. Two weeks postinfection, and even more strikingly after 4 wk, we observed that Ly49C expression correlated with a reduced presence of Ly49H + memory NK cells; on average, 34.3% of Ly49H + NK cells coexpressed Ly49C + , whereas 65.4% were Ly49C 2 , which corresponded to the persistence of 1762 and 3257 memory NK cells in the spleen, respectively. The reduction was even more pronounced when NK cells originated from Ly49C-Tg mice compared with from WT mice; on average, 0.2% of Ly49H + NK cells were derived from Ly49C-Tg donor mice, which corresponded to 11 splenic memory NK cells (Fig. 7C, data not shown) . Therefore, Ly49Cmediated licensing does not dramatically change NK cell antiviral responses during acute MCMV infection, but it strongly impairs the generation and/or persistence of memory NK cells. 
Discussion
In this study, we used a unique combination of mouse strains expressing the Ly49C inhibitory receptor in the presence or absence of its endogenous ligand to get a better understanding of the role of licensing in NK cell biology. In the bone marrow, Ly49C was expressed early during NK cell development, as demonstrated by the presence of a small population of CD122 + NK11 2 stage I NK cell precursors expressing low levels of Ly49C in non-Tg mice. Optimal expression, both in frequency and density, was observed at later stages (IV/V) in WT and b2m-ko mice, suggesting that Ly49C expression kinetics are not controlled by MHC I, even though the presence of MHC I molecules calibrates the level of expression of the self-specific inhibitory receptors and the NK cell repertoire (34, 35) . Numbers of NK1.1 + precursors (stage II onward) were reduced in Ly49C-Tg mice on the b2m-sufficient and b2m-deficient backgrounds, which indicated that inhibitory receptors resulted in accelerated development kinetics and/or in-creased precursor mortality. We observed a similar distribution profile of the precursors at the successive developmental stages, but we found higher apoptosis rates in B6 Ly49C-Tg mice at stage IV/V than in B6 WT mice. The fact that we detected increased apoptosis in Ly49C-Tg NK cells, but not in Ly49C + NK cells, in WT mice may be explained by the higher levels of expression of the receptor in the Tg mice than in the non-Tg mice. This suggests that precursor cells receiving excess inhibitory signals are deleted during education. Increased proliferation occurred simultaneously, which offset the cell loss and resulted in an unchanged frequency of precursors throughout the successive developmental stages. It is also possible that altered homing properties in Ly49C + NK cells were responsible, in part, for the reduction in bone marrow NK1.1 + cells. The presence of more NK cells in the spleen in B6 Ly49C-Tg mice than in B6 WT mice concurs with this hypothesis. Analysis of Ly49C 2 and Ly49C + precursors in B6 WT mice also demonstrated that expression of the receptor in the presence of its ligand promoted proliferation at late stages of development, in accordance with previous findings (29) .
The term "repertoire" defines the variety of receptors expressed on individual NK cells and the frequency of cells expressing each type of receptor in the entire NK cell population. The variety of receptors available is genetically encoded, but the factors that regulate their expression are yet to be fully understood. In B6 Ly49C-Tg mice, lower frequencies of cells expressed Ly49A, Ly49G2, and Ly49D, whereas DNAM-1 + cells were more frequent. NKG2D, which is ubiquitously expressed on NK cells, was present at a higher density on B6 Ly49C-Tg NK cells than on WT cells. Expression of Ly49H, NKG2A/C/E, and 2B4 were unchanged. The decreased expression of endogenous Ly49A, Ly49G2, and Ly49D that we observed reproduces the findings reported in B6 Ly49A/C-Tg mice (31) . Likewise, DNAM-1 is preferentially expressed in combination with self-specific KIRs in human NK cells (36) . The NK cell repertoire was shown to be influenced by a combination of qualitative and quantitative factors in relation to MHC I molecules (e.g., the affinity of the receptors for these ligands and the number of alleles present) (37) . Repertoire alterations in Ly49C-Tg mice might depend on several factors. Ly49A, Ly49G2, and Ly49D do not possess any known endogenous ligands in H-2 b mice; thus, the presence of ligands is not a parameter that drives which receptors are affected. Competition for the receptor signaling molecules might be responsible for reduced expression of inhibitory (Ly49A, Ly49G2) receptors, but it cannot account for the decreased expression of activating receptors (Ly49D) because they use different signaling molecules. Ly49A expression is controlled by the transcription factor TCF-1, and TCF-1-deficient NK cells display a quasi-complete absence of Ly49A + cells, a reduced Ly49D + subset, and increased Ly49G2 + subsets (38) , which only partially fits with the changes that we observed. In addition, endogenous Ly49C expression is not affected by TCF-1 deficiency (38) . Expression of the Ly49C, Ly49A, Ly49G2, and Ly49D genes is under the control of different transcription factors; therefore, we can exclude that the differences in expression profiles that we identified were due to competition associated with limited transcription factor availability. Reduced expression of Ly49A, Ly49G2, and NKG2D did not occur in B6 b2m-ko Ly49C-Tg mice, whereas changes affecting Ly49D and DNAM-1 were still detected. Overall, our results support the concept that Ly49C engagement with MHC I is responsible for most of the repertoire alterations.
We found that expression of three activating receptors (Ly49H, Ly49D, and NKG2D) was differentially altered in B6 Ly49C-Tg mice compared with WT mice. Ly49H expression was unaffected, Ly49D distribution was reduced, and the NKG2D ex- pression level was increased. The expression of these receptors may be differentially controlled. Ligand binding, for example, can trigger receptor expression changes; however, neither Ly49H nor Ly49D has known endogenous ligands in naive B6 mice, and NKG2D recognizes stress-induced ligands. The three receptors share the same adaptors, DAP10 and DAP12, so a deficit in DAP10/ 12 is unlikely to be responsible for the differential expression noted in our study, unless differential affinity of the receptors for these adaptors resulted in preferential association if limited amounts of adaptors were available. Because Ly49C does not require DAP10/ 12, an effect of the transgene on adaptor content is unlikely. Differences in gene regulation could also account for differences in receptor expression. Several transcription factors play a role during NK cell development and repertoire acquisition. E4bp4-deficient NK cells display reduced expression of NKG2D (39), but the impact on Ly49D and Ly49H expression was not evaluated. Absence of the transcription factor Ets1 resulted in decreased frequencies of NK cells expressing Ly49H and Ly49D, whereas NKG2D distribution was not affected (40) . Eomes-deficient NK cells exhibited reduced distribution of Ly49A, D, G2, and H receptors (41) . None of the repertoire alterations associated with the absence of these transcription factors match the profile that we identified in Ly49C-Tg mice. The expression of activating receptors, such as Ly49D and Ly49H, is inversely correlated with the level of DNA methylation on regulating sequences; different DNA methylation patterns were found for Ly49d and Ly49h (42) . This may provide directions in future studies aiming at better understanding the mechanisms that regulate NK cell repertoire regulation.
Two education models have been proposed. In the selection model, a finite set of NK cell receptor genes is stochastically expressed on developing NK cells, which are then tested for selfrecognition. In the alternative sequential-expression model, precursors acquire new receptors until proper recognition of self is achieved (1) . The existence of mature NK cells devoid of selfspecific inhibitory receptors in the periphery (15) implies that the failure to express such receptors during development does not lead to deletion. However, only NK cells that possess self-specific inhibitory receptors become fully functional, whereas the others remain or become hyporesponsive, depending on whether education constitutes an arming process or whether NK cells are active by default. Higher apoptosis rates measured at developmental stages IV/V in licensed NK cells in Ly49C-Tg mice, but not in WT mice, could be due to the higher Ly49C expression levels in Tg mice. We found that Ly49 expression gradually increases in frequency and in density during development; therefore, it is possible that NK cells that received too much inhibitory signal in the presence of MHC I ligands underwent apoptosis, which would occur mostly late during development when optimal expression of endogenous Ly49s was achieved. This could provide a selection mechanism mediated by MHC I through inhibitory self-specific receptors during NK cell development. Both of the selection models described above are consistent with the regulated proliferation and apoptosis rates that we observed in Ly49C + NK cells; however, considering that Ly49C is expressed at near-optimal levels early during development in Ly49C-Tg mice, one might have predicted that a sequential model scenario would be associated with obvious changes in development kinetics and in the distribution of precursors at the successive developmental stages. Thus, our observations favor a stochastic selection model, in agreement with Johansson et al. (43) .
A positive effect of Ly49C on proliferation was also detected in splenic NK cells. This effect was most pronounced at the early and intermediate CD27 hi stages of maturation. In the absence of stimulation, peripheral NK cells proliferate only weakly (44) . Therefore, the presence of BrdU + NK cells in the spleen likely reflects a primarily recent influx of newly developed cells that had proliferated while completing development in the bone marrow. Hayakawa and Smyth (32) showed, by transferring bone marrow cells into lethally irradiated mice, that the splenic NK cell population consisted primarily of CD27 hi CD11b lo cells 1 wk after reconstitution, whereas a defined CD27 hi CD11b hi population could only be detected after 2 wk and after 4 wk for the most mature CD27 lo CD11b hi cells. Such transition times between the maturation stages indicate that the increased BrdU incorporation in the intermediate and most mature NK cell subsets that we observed occurred within the spleen. These results suggest that Ly49C-driven licensing promotes peripheral NK cell proliferation, even in the absence of pathogenic conditions. We tested the impact of licensing on NK cell functions. For in vitro experiments, to measure functions that reflected, as much as possible, NK cell behavior in natural conditions, we used NK cells directly ex vivo without a phase of in vitro activation and expansion with IL-2. First, NK cells were stimulated using receptor crosslinking. We confirmed that licensed NK cells stimulated through NK1.1 displayed increased IFN-g production in Ly49C-Tg NK cells. In addition, we found that Ly49C expression correlated with improved NK cell activity in response to stimulation of NKp46, NKG2D, Ly49H, and, to a lesser extent, DNAM-1 and CD16. Analysis of the intensity of IFN-g production in B6 Ly49C-Tg NK cells at the single-cell level confirmed a stronger activity following cross-linking of NK1.1, NKp46, NKG2D, Ly49H, and Ly49D. The increased cytokine production (MFI) in response to Ly49D in B6 Ly49C-Tg NK cells compared with B6 WT NK cells was not correlated to a larger population of IFN-g-producing cells; this was most likely due to the reduced abundance of Ly49D + cells in Ly49C-Tg mice. Conversely, slightly more NK cells responded following DNAM-1 cross-linking, whereas similar amounts of IFN-g were measured intracellularly in WT and Ly49C-Tg mice; because more NK cells from Ly49C-Tg mice express DNAM-1, the increased DNAM-1-induced response associated with licensing was not true at the single-cell level, only at the level of the NK cell population. The absence of b2m abrogated the positive effect of licensing observed in Ly49C-Tg mice, which indicates that licensing requires the presence of MHC I molecules that bind to Ly49C. It was reported that licensing was preserved in mice deficient in SHP-1, an essential molecule involved in inhibitory Ly49 receptor signaling, which suggested that licensing was mediated through ITIM-independent mechanisms (9); however, this finding remains controversial because other studies showed that functional ITIMs are required for licensing (45) (46) (47) . The molecular mechanisms that control licensing by self-specific inhibitory receptors remain to be defined. NK cell activation is triggered by signals downstream of activating receptors and is regulated by inhibitory receptors. Two main pathways that negatively control NK cell activation have been identified. The phosphorylation of Vav1 downstream of activating receptor engagement is a critical checkpoint, because the tyrosine phosphatase SHP-1, which is recruited by engaged inhibitory receptors, can dephosphorylate Vav1 and terminate the activation process (48) . Crk is another critical regulator of NK cell activation; inhibitory receptors induce Crk phosphorylation and regulate F-actin network formation and activating receptor-dependent signaling (49) . Disruption of the cytoskeleton reorganization may regulate NK cell activation in parallel or upstream of Vav1 phosphorylation. Guia et al. (16) showed that activating receptor movements on the cell membrane were more constrained in the absence of MHC I molecules and were associated with hyporesponsiveness. It is possible that the reduced inhibitory receptor-induced phosphorylation of Crk was responsible for this altered mobility and may reflect a molecular mechanism responsible for NK cell licensing.
Although all NK cells are supposedly licensed in Ly49C-Tg mice, we did not observe a significantly increased population that responded to RMAS ex vivo, which actually confirmed what was reported previously (21) . However, we measured more IFN-g accumulation in responding NK cells from Ly49C-Tg mice than from WT mice. We found that licensing promoted IFN-g responses following exposure of NK cells to YAC-1, CHO, and RMAS labeled with anti-Thy1.2 Abs, used as targets that express ligands for NKG2D, Ly49D, and CD16, respectively. Conversely, licensing did not improve cytotoxicity in the same conditions, indicating a split effect of licensing on NK cell functions. Interestingly, administration of poly(I:C) did not reverse the hyporesponsiveness associated with the absence of NK cell licensing, but this treatment better demonstrated the improved functions in educated compared with uneducated NK cells. These results indicate that, under these conditions, inflammatory cytokines induced by poly(I:C) cannot compensate for the lack of education. Two main mechanisms can explain how MHC I molecules regulate NK cells through inhibitory receptors. Interactions usually occur in trans when a receptor binds a ligand expressed on another cell (trans interaction), but some receptors, including Ly49C (24, 50) , are able to bend and engage ligands expressed in the vicinity on the cell membrane (cis interaction). Ly49A was shown to be able to engage H-2 D d both in trans and in cis (51); Held and colleagues (45, 46) generated recombinant mice expressing a mutant Ly49A with an altered stalk domain that was unable to interact with MHC I in cis while retaining the ability to engage H-2 D d expressed in trans; they showed that the inhibitory function of such receptors was preserved while licensing was impaired, which highlighted the role of cis interactions in licensing. It is possible that the absence of cis interactions, combined with the elevated expression of Ly49C in b2m-ko Ly49C-Tg mice, is responsible for the severe hyporeactivity. The tolerized missing self-recognition function in b2m-ko NK cells is restored in inflammatory conditions associated with MCMV infection (52) . Likewise, we found that NK cells respond in a Ly49H-dependent manner in response to MCMV infection in b2m-ko and b2m-ko Ly49C-Tg mice (24) (C.A. Forbes and J.D. Coudert, unpublished observations).
In in vitro functional assays, the presence of the Ly49C transgene in b2m-deficient NK cells was associated with reduced degranulation in response to NKG2D engagement (exposure to YAC-1) compared with B6 b2m-ko NK cells. Because there is no ligand for Ly49C on YAC-1 cells, it is most unlikely that Ly49C-dependent inhibition interferes with activating receptor signaling. Receptors were found to compartmentalize in membrane nanodomains on educated NK cells, whereas in the absence of MHC I, activating and inhibitory receptors are confined to an actin meshwork at the plasma membrane (16) . It is possible that, in the absence of cis binding to MHC I molecules, Ly49C localizes in domains of the membrane in such a way that affects NKG2D function.
Due to the nature of the expression vector that we used to generate the B6 Ly49C-Tg mouse strain, Ly49C is expressed on 50-70% of T cells and on ,20% of B cells, in addition to NK cells (24) . MHC I H2-K b molecules and Ly49C interact in cis, which may mask a fraction of MHC I molecules and result in an altered MHC I display on Ly49C-expressing lymphocytes. Mature lymphocytes, such as T and B cells, are present in the bone marrow alongside NK cells and constitute a pool of cells with apparently reduced MHC I expression; is it possible that they influence developing NK cell proliferation and apoptosis? In a recent study, Bessoles et al. (45) specifically ablated MHC I H-2 D d expression from the entire T cell population; this modification prevented NK cell-mediated rejection of allogeneic splenocytes, whereas MHC I-devoid splenocytes were efficiently killed. Furthermore, the presence of only 10% of T cells that lacked MHC I D d was sufficient to significantly alter NK cell responsiveness to targets, indicating that cell type-specific MHC I ablation alters NK cell cytotoxicity. A similar modification of the NK cell response was reported in H-2 D d mosaic mice, in which D d expression was deleted in only a fraction of the total cells (53) . In our model, we do not have a complete absence of MHC I K b on a fraction of T and B cells; rather, there is likely a reduced expression as a result of cis binding. Jonsson and coworkers (54) found that Ly49A + NK cells are equally licensed in MHC I hemizygous and homozygous mice, indicating that, at least for some receptor-ligands pairs, a single MHC I allele is sufficient to license NK cells with cytotoxic capability. Brodin http://www.jimmunol.org/ trigger NK cell responses; they found that NK cells are quite tolerant to cells with decreased expression of MHC I and that levels had to fall below 20% of normal to trigger cytotoxicity. Therefore, it is unlikely that reduced expression of MHC I molecules on T and B cells (due to Ly49C expression) led to altered NK cell functions in our settings; however, we cannot exclude that it might have played a role in altered proliferation and apoptosis in developing NK cells. Mature NK cells with cis-engaged MHC I are also present in the bone marrow in WT and Ly49C-Tg mice, and it is possible that they may also play a similar role. When tested in vivo in the context of acute infection by MCMV, NK cells from Ly49C-Tg mice displayed signs of activation, such as CD69 and KLRG1 upregulation. During the course of MCMV infection, inflammatory cytokines drive the early and nonspecific NK cell activation, whereas later, Ly49H + NK cells are responsible for the specific antiviral response in B6 mice (56) . We found that NK cells control MCMV infection equally well in B6 Ly49C-Tg and B6 WT mice, which confirmed that Ly49H-dependent recognition and subsequent killing of infected cells was functional in vivo. A role for licensing in improving NK cell function was challenged in studies of the antiviral response against MCMV (21) . This study found that Ly49C/I + NK cells expanded significantly less than their Ly49C/I 2 counterparts during the course of MCMV infection in H-2 b mice and that Ly49C/I + cell depletion had only a minor effect on MCMV titers in the liver and salivary glands. It was concluded that engagement of MHC I on MCMVinfected cells by Ly49C/I limited NK cell activation and abrogated the functional gain due to licensing, whereas unlicensed NK cells that were not inhibited through Ly49C/I had their functions enhanced in the inflammatory environment. Conversely, it was shown in another in vivo system that licensed Ly49G2 + NK cells in H-2 k mice were more efficient at controlling MCMV than unlicensed NK cells (57) . MCMV-specific Ly49H + NK cells exert strong cytotoxicity against infected cells, as well as cytokine production and subset expansion (58, 59) . It was determined that licensing is dispensable for the NK cell response to MCMV infection and the efficient control of viral replication in b2mdeficient mice [J.D. Coudert, unpublished observations; (52) ]. We found in this study that MCMV infection was well controlled by NK cells in B6 Ly49C-Tg and WT mice. These results indicate that licensed NK cells are proficient at mediating antiviral protection against MCMV.
Once infection has been controlled, effector NK cells undergo a phase of contraction, whereas long-lived memory NK cells with improved functions remain detectable for months (5) . We analyzed whether licensing provided an advantage during the memory cell differentiation and/or persistence process and found that Ly49C expression actually resulted in a reduced memory NK cell population. Interestingly, we observed that differentiation/persistence of NK cells originating from Ly49C-Tg mice were even more severely impaired than those of Ly49C + NK cells from WT mice. Therefore, the transgene expression has impaired the persistence of Ly49H + cells at a month postinfection. A vast majority of Ly49C molecules are masked by H-2 K b molecules through interactions in cis on B6 WT NK cells, whereas on Ly49C-Tg NK cells, more Ly49C molecules are free because of the higher expression level of the receptor (data not shown). These molecules are able to interact with H-2 K b ligands expressed in trans and are also likely to have a greater mobility on the cell membrane, as reported (16, 60) . Therefore, it is possible that the extent of Ly49C receptors engaged through cis interactions plays a role in memory NK cell differentiation and/or persistence. It was reported that DNAM-1 plays an essential role in optimal differentiation of memory NK cells during MCMV infection (61) . We observed that the DNAM-1 + population was increased in B6 Ly49C-Tg mice; thus, our results suggest that, although DNAM-1 is essential for memory cell differentiation, it is not sufficient. A recent study demonstrated that KLRG1 hi NK cells proliferate poorly in response to MCMV infection and cannot properly differentiate into memory NK cells (62) . Likewise, NK cells lacking RAG display a mature phenotype with an increased CD11b hi NK cell subset and high KLRG1 expression. Furthermore, these NK cells demonstrate a reduced capacity for memory cell generation (63) , similar to what we observed for Ly49C-Tg NK cells, in which upregulation of KLRG1 was detected after MCMV infection. Because RAGdeficient NK cells have a reduced capacity to repair DNA damage, which results in increased apoptosis, it will be interesting to evaluate in future studies whether similar mechanisms occur in licensed NK cells.
Higher Ly49C levels were detected on NK cells in Tg mice compared with WT mice. This elevated Ly49C expression may change the ratio of receptors engaged in cis. An increased abundance of Ly49C is likely to result in more receptors that can engage ligands in trans, resulting in increased inhibitory signals; this may also alter the mobility and distribution of receptors on the cell surface. It is possible that some of the effects reported in this study relate to an altered cis/trans balance. We found increased apoptosis in peripheral NK cells in B6 Ly49C-Tg mice; therefore, it is possible that an altered cis/trans balance is responsible, at least in part, for the impaired generation/persistence of memory NK cells following MCMV infection. The data obtained using Ly49C-Tg mice offer novel insights into the potential role of cis interactions in NK cell development and function and provide the basis for future studies.
